377 related articles for article (PubMed ID: 31843271)
1. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
Constable C; Caplan A
Vaccine; 2020 Jan; 38(5):954-962. PubMed ID: 31843271
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
3. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
4. Early lessons learned from extramural school programs that offer HPV vaccine.
Hayes KA; Entzel P; Berger W; Caskey RN; Shlay JC; Stubbs BW; Smith JS; Brewer NT
J Sch Health; 2013 Feb; 83(2):119-26. PubMed ID: 23331272
[TBL] [Abstract][Full Text] [Related]
5. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV.
Masserey Spicher V; Weiss MG
Vaccine; 2019 Dec; 37(52):7539-7546. PubMed ID: 31630937
[TBL] [Abstract][Full Text] [Related]
6. On surmounting the barriers to HPV vaccination: we can do better.
Attia AC; Wolf J; Núñez AE
Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
[TBL] [Abstract][Full Text] [Related]
7. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.
Laugesen MJ; Mistry R; Carameli KA; Ribisl KM; Needleman J; Bastani R
J Adolesc Health; 2014 Nov; 55(5):659-64. PubMed ID: 24928803
[TBL] [Abstract][Full Text] [Related]
8. "I think they're all basically the same": parents' perceptions of human papilloma virus (HPV) vaccine compared with other adolescent vaccines.
Ogunbajo A; Hansen CE; North AL; Okoloko E; Niccolai LM
Child Care Health Dev; 2016 Jul; 42(4):582-7. PubMed ID: 26990908
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
Glenn BA; Nonzee NJ; Tieu L; Pedone B; Cowgill BO; Bastani R
Vaccine; 2021 Jun; 39(25):3435-3444. PubMed ID: 33992435
[TBL] [Abstract][Full Text] [Related]
10. Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
Selvey LA; Roux F; Burns S
Vaccine; 2020 Mar; 38(14):2971-2977. PubMed ID: 32115296
[TBL] [Abstract][Full Text] [Related]
11. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
12. School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas.
Kaul S; Do TQN; Hsu E; Schmeler KM; Montealegre JR; Rodriguez AM
Papillomavirus Res; 2019 Dec; 8():100189. PubMed ID: 31654772
[TBL] [Abstract][Full Text] [Related]
13. Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.
Vercruysse J; Chigurupati NL; Fung L; Apte G; Pierre-Joseph N; Perkins RB
Hum Vaccin Immunother; 2016 Jun; 12(6):1606-14. PubMed ID: 26934421
[TBL] [Abstract][Full Text] [Related]
14. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.
Newcomer SR; Caringi J; Jones B; Coyle E; Schehl T; Daley MF
Public Health Rep; 2020; 135(6):842-850. PubMed ID: 32972304
[TBL] [Abstract][Full Text] [Related]
15. Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine.
Tsai HJ
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):112-5. PubMed ID: 25951712
[TBL] [Abstract][Full Text] [Related]
16. Impact of school-entry and education mandates by states on HPV vaccination coverage: Analysis of the 2009-2013 National Immunization Survey-Teen.
Perkins RB; Lin M; Wallington SF; Hanchate AD
Hum Vaccin Immunother; 2016 Jun; 12(6):1615-22. PubMed ID: 27152418
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons.
Donahue KL; Stupiansky NW; Alexander AB; Zimet GD
Vaccine; 2014 Jun; 32(31):3883-5. PubMed ID: 24844150
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine introduction--the first five years.
Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
[TBL] [Abstract][Full Text] [Related]
19. Adolescent human papillomavirus vaccination in the United States: Opportunities for integrating pharmacies into the immunization neighborhood.
Fava JP; Colleran J; Bignasci F; Cha R; Kilgore PE
Hum Vaccin Immunother; 2017 Aug; 13(8):1844-1855. PubMed ID: 28605256
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
Wheeler CM; Bautista OM; Tomassini JE; Nelson M; Sattler CA; Barr E;
Vaccine; 2008 Jan; 26(5):686-96. PubMed ID: 18164106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
